Fibrotech Therapeutics

In 2014, Fibrotech was acquired by Shire, a global specialty biopharmaceutical company, for an upfront of US$75 million payment and further milestone payments of US$482.5m, making the total deal US$557.5m.

Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.